Health regulator authorizes Indian company to sell first generic Ozempic in Canada
Health Canada has authorized Dr. Reddy’s Laboratories Ltd. to sell the first generic version of Ozempic in Canada. This approval follows a delay of nearly four months since generic Ozempic became legal in the country. The introduction of the generic drug is expected to significantly reduce costs for patients and health insurance plans.
- ▪Dr. Reddy’s Laboratories Ltd. is the first company approved to sell a generic version of Ozempic in Canada.
- ▪The generic version is expected to offer discounts of up to 65 percent for patients and health insurance plans.
- ▪Currently, over a million Canadians take semaglutide, and the number is expected to grow with the availability of generics.
Opening excerpt (first ~120 words) tap to expand
Open this photo in gallery:A doctor in Mumbai displays the Ozempic GLP-1 self-injectable at a clinic.INDRANIL MUKHERJEE/AFP/Getty ImagesShareSave for laterPlease log in to bookmark this story.Log InCreate Free AccountIndian pharmaceutical company Dr. Reddy’s Laboratories Ltd. has become the first drug maker approved by Health Canada to sell a generic version of the blockbuster drug Ozempic.The authorization comes nearly four months after generic Ozempic became legal in Canada, a delay longer than many manufacturers, physicians and patients had been hoping for.The development means those taking the drugs will potentially receive significant discounts, eventually as much as 65 per cent off, as will public and private health insurance plans that have seen costs balloon because of growing…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Globe and Mail.
Discussion
0 commentsMore from The Globe and Mail
